Bluebird Bio Valuation
| BLUEDelisted Stock | USD 4.97 0.23 4.85% |
At this time, the firm appears to be overvalued. Bluebird Bio shows a prevailing Real Value of $3.93 per share. The current price of the firm is $4.97. Our model approximates the value of Bluebird Bio from analyzing the firm fundamentals such as Current Valuation of 158.07 M, profit margin of (1.92) %, and Return On Equity of -5.47 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bluebird Bio's price fluctuation is very steady at this time. Calculation of the real value of Bluebird Bio is based on 3 months time horizon. Increasing Bluebird Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bluebird stock is determined by what a typical buyer is willing to pay for full or partial control of Bluebird Bio. Since Bluebird Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bluebird Stock. However, Bluebird Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.97 | Real 3.93 | Hype 4.97 | Naive 4.68 |
The real value of Bluebird Stock, also known as its intrinsic value, is the underlying worth of Bluebird Bio Company, which is reflected in its stock price. It is based on Bluebird Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bluebird Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bluebird Bio helps investors to forecast how Bluebird stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bluebird Bio more accurately as focusing exclusively on Bluebird Bio's fundamentals will not take into account other important factors: About Bluebird Bio Valuation
The delisted stock valuation mechanism determines Bluebird Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bluebird Bio. We calculate exposure to Bluebird Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bluebird Bio's related companies.bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts. Bluebird Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 518 people.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Bluebird Stock
If you are still planning to invest in Bluebird Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bluebird Bio's history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |